{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"diazoxide-resistant-focal-hyperinsulinism-due-to-kir6-2-deficiency","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"A rare, congenital, isolated hyperinsulinism disorder characterized by diazoxide unresponsive recurrent episodes of hyperinsulinemic hypoglycemia resulting from an excessive insulin secretion by the pancreatic bêta-cells due to Kir6.2 deficiency. Hypoglycemia may lead to variable clinical manifestation, ranging from asymptomatic hypoglycemia revealed by routine blood glucose monitoring to macrosomia at birth, mild to moderate hepatomegaly and life-threatening hypoglycemic coma or status epilepticus, further leading to poor neurological outcome.","mondoId":"MONDO:0017188","node":{"canonicalSlug":"diazoxide-resistant-focal-hyperinsulinism-due-to-kir6-2-deficiency","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency","originalSourceId":"ORPHA:276603","paragraphs":["A rare, congenital, isolated hyperinsulinism disorder characterized by diazoxide unresponsive recurrent episodes of hyperinsulinemic hypoglycemia resulting from an excessive insulin secretion by the pancreatic bêta-cells due to Kir6.2 deficiency. Hypoglycemia may lead to variable clinical manifestation, ranging from asymptomatic hypoglycemia revealed by routine blood glucose monitoring to macrosomia at birth, mild to moderate hepatomegaly and life-threatening hypoglycemic coma or status epilepticus, further leading to poor neurological outcome."],"rawAttribution":"ORPHA:276603","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:42:20Z","upstream":"ORPHA:276603","url":"https://rarediseases.info.nih.gov/diseases/17286"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"hyperinsulinemic hypoglycemia, familial, 2","mondoId":"MONDO:0011153","slug":"hyperinsulinemic-hypoglycemia-familial-2"},{"kind":"parent","label":"diazoxide-resistant focal hyperinsulinism","mondoId":"MONDO:0019265","slug":"diazoxide-resistant-focal-hyperinsulinism"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17286\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:276603</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare, congenital, isolated hyperinsulinism disorder characterized by diazoxide unresponsive recurrent episodes of hyperinsulinemic hypoglycemia resulting from an excessive insulin secretion by the pancreatic bêta-cells due to Kir6.2 deficiency. Hypoglycemia may lead to variable clinical manifestation, ranging from asymptomatic hypoglycemia revealed by routine blood glucose monitoring to macrosomia at birth, mild to moderate hepatomegaly and life-threatening hypoglycemic coma or status epilepticus, further leading to poor neurological outcome.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17286\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"diazoxide-resistant-focal-hyperinsulinism-due-to-kir6-2-deficiency","sourceDocuments":[{"name":"GARD: Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency","reviewed":null,"source_release":"2026-10-25T03:42:20Z","url":"https://rarediseases.info.nih.gov/diseases/17286"}],"sourceNote":"","synonyms":["hyperinsulinemic hypoglycemia due to Kir6.2 deficiency, diazoxide-resistant focal form"],"takeawayHtml":"","title":"diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency"},"schemaVersion":1}
